ramucirumab
CYRAMZA is classified as formulary status, restricted to Oncology in the OUTPATIENT setting.
Reviewed: September 23, 2014 (Cyramza)
CYRAMZA is classified as formulary status, restricted to Oncology in the OUTPATIENT setting.
Reviewed: September 23, 2014 (Cyramza)